So Okubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
So Okubo has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Takashi Matsukawa
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan
3 shared publications Ayumi Uchibori
Department of Neurology, Faculty of Medicine Kyorin University Tokyo Japan
2 shared publications- Hiroya Naruse
Department of Neurology, Graduate School of Medicine The University of Tokyo Tokyo Japan
2 shared publications Jun Mitsui
Department of Neurology, Graduate School of Medicine The University of Tokyo Tokyo Japan
2 shared publicationsMasashi Hamada
Department of Neurology, Graduate School of Medicine The University of Tokyo Tokyo Japan
2 shared publications- Meiko Maeda
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan
2 shared publications
Latest Publications
- 1 October 2026
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 12 (5)
LRP12 CGG Repeat Expansions in Patients With Adult-Onset Non-5q Spinal Muscular Atrophy
- 1 October 2026
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 12 (5)
LRP12 CGG Repeat Expansions in Patients With Adult-Onset Non-5q Spinal Muscular Atrophy
- Open Access
- 19 November 2025
- Published by Wiley in Annals of Neurology
- Vol. 99 (1) , 223-230
A Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant
Pathogenic DMD variants usually follow the reading‐frame rule: out‐of‐frame changes cause Duchenne muscular dystrophy, whereas in‐frame ones produce Becker muscular dystrophy (BMD). We report a 23‐year‐old man with BMD‐like weakness, calf hypertrophy, elevated creatine kinase, and dilated cardiomyopathy. A novel hemizygous c.2281delG variant converted an A₄GA₅ motif to A₉, predicting a frameshift; however, Western blot showed ~15% full‐length dystrophin. cDNA and polymerse chain reaction (PCR)‐free direct RNA sequencing demonstrated transcriptional slippage, adding 1 adenine (A₁₀) that restores the reading frame and dystrophin. This RNA‐level rescue of an out‐of‐frame DMD variant explains the mild phenotype and highlights the importance of transcript‐level analysis in dystrophinopathies. ANN NEUROL 2026;99:223–230
- 19 November 2025
- Published by Wiley in Annals of Neurology
- Vol. 99 (1) , 223-230
Open AccessA Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant
Pathogenic DMD variants usually follow the reading‐frame rule: out‐of‐frame changes cause Duchenne muscular dystrophy, whereas in‐frame ones produce Becker muscular dystrophy (BMD). We report a 23‐year‐old man with BMD‐like weakness, calf hypertrophy, elevated creatine kinase, and dilated cardiomyopathy. A novel hemizygous c.2281delG variant converted an A₄GA₅ motif to A₉, predicting a frameshift; however, Western blot showed ~15% full‐length dystrophin. cDNA and polymerse chain reaction (PCR)‐free direct RNA sequencing demonstrated transcriptional slippage, adding 1 adenine (A₁₀) that restores the reading frame and dystrophin. This RNA‐level rescue of an out‐of‐frame DMD variant explains the mild phenotype and highlights the importance of transcript‐level analysis in dystrophinopathies. ANN NEUROL 2026;99:223–230
- Open Access
- 22 April 2025
- Published by Springer Nature in Journal of Human Genetics
- Vol. 70 (7) , 381-384
Elevated serum autotaxin levels and multiple system atrophy-like presentation in a patient with PLA2G6-associated neurodegeneration
PLA2G6-associated neurodegeneration (PLAN) encompasses a spectrum of phenotypes caused by biallelic pathogenic variants in PLA2G6. Initially linked to infantile and atypical neuroaxonal dystrophy, PLAN now includes adult-onset conditions such as dystonia-parkinsonism, ataxia, and spastic paraplegia. We report a female patient presenting young-onset parkinsonism with pyramidal tract signs, cerebellar atrophy, and autonomic dysfunction, mimicking multiple system atrophy (MSA). Neuroimaging showed decreased dopamine uptake and cerebellar hypoperfusion. Genetic analysis identified a homozygous pathogenic variant in PLA2G6 (c.967G>A, p.Val323Met), confirming a diagnosis of PLAN. Interestingly, elevated serum autotaxin levels (4.67 ng/mL) without liver abnormalities. Bilateral brachymetatarsia was also observed, which may indicate an association with the PLA2G6 variant. This case underscores the importance of considering PLAN in cases of young-onset parkinsonism with multisystem involvement. Genetic testing is crucial for accurate diagnosis and management of such cases. Elevated serum autotaxin levels may be associated with decreased phospholipase activity in PLAN and warrants further investigation.
- 22 April 2025
- Published by Springer Nature in Journal of Human Genetics
- Vol. 70 (7) , 381-384
Open AccessElevated serum autotaxin levels and multiple system atrophy-like presentation in a patient with PLA2G6-associated neurodegeneration
PLA2G6-associated neurodegeneration (PLAN) encompasses a spectrum of phenotypes caused by biallelic pathogenic variants in PLA2G6. Initially linked to infantile and atypical neuroaxonal dystrophy, PLAN now includes adult-onset conditions such as dystonia-parkinsonism, ataxia, and spastic paraplegia. We report a female patient presenting young-onset parkinsonism with pyramidal tract signs, cerebellar atrophy, and autonomic dysfunction, mimicking multiple system atrophy (MSA). Neuroimaging showed decreased dopamine uptake and cerebellar hypoperfusion. Genetic analysis identified a homozygous pathogenic variant in PLA2G6 (c.967G>A, p.Val323Met), confirming a diagnosis of PLAN. Interestingly, elevated serum autotaxin levels (4.67 ng/mL) without liver abnormalities. Bilateral brachymetatarsia was also observed, which may indicate an association with the PLA2G6 variant. This case underscores the importance of considering PLAN in cases of young-onset parkinsonism with multisystem involvement. Genetic testing is crucial for accurate diagnosis and management of such cases. Elevated serum autotaxin levels may be associated with decreased phospholipase activity in PLAN and warrants further investigation.
- 18 February 2024
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 15 (3) , 137-142
Dropped head syndrome in anti‐MuSK antibody‐positive myasthenia gravis with possible concurrent axial myopathy
Background: Dropped head syndrome (DHS) is a group of disorders that result in anterior neck flexion. Myasthenia gravis (MG) is a common cause of DHS. Previous reports have suggested that concurrent myopathy involving the paraspinal musculature may underlie DHS in patients with anti‐acetylcholine receptor antibody‐positive or thymoma‐associated MG.Case Presentation: A 64‐year‐old woman presented with a 3‐month history of head drop and lordosis. Neurological examination revealed bilateral ptosis and weakness of the posterior neck extensors. Electrophysiology suggested neuromuscular junction involvement. Serum anti‐MuSK antibodies were positive, and generalized anti‐MuSK antibody‐positive myasthenia gravis (MuSK‐MG) was diagnosed. Needle electromyography (nEMG) of the splenius capitus and paraspinal muscles revealed acute and chronic myogenic changes. Imaging suggested paraspinal muscle atrophy. nEMG and magnetic resonance imaging (MRI) of both extremities were normal, and autoimmune myopathy‐related antibody testing was negative.Conclusion: Thymoma‐negative MuSK‐MG, demonstrating treatment‐refractory DHS, may present with concurrent axial myopathy.
- 18 February 2024
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 15 (3) , 137-142
Dropped head syndrome in anti‐MuSK antibody‐positive myasthenia gravis with possible concurrent axial myopathy
Background: Dropped head syndrome (DHS) is a group of disorders that result in anterior neck flexion. Myasthenia gravis (MG) is a common cause of DHS. Previous reports have suggested that concurrent myopathy involving the paraspinal musculature may underlie DHS in patients with anti‐acetylcholine receptor antibody‐positive or thymoma‐associated MG.Case Presentation: A 64‐year‐old woman presented with a 3‐month history of head drop and lordosis. Neurological examination revealed bilateral ptosis and weakness of the posterior neck extensors. Electrophysiology suggested neuromuscular junction involvement. Serum anti‐MuSK antibodies were positive, and generalized anti‐MuSK antibody‐positive myasthenia gravis (MuSK‐MG) was diagnosed. Needle electromyography (nEMG) of the splenius capitus and paraspinal muscles revealed acute and chronic myogenic changes. Imaging suggested paraspinal muscle atrophy. nEMG and magnetic resonance imaging (MRI) of both extremities were normal, and autoimmune myopathy‐related antibody testing was negative.Conclusion: Thymoma‐negative MuSK‐MG, demonstrating treatment‐refractory DHS, may present with concurrent axial myopathy.